Genezen is attending The European Society of Gene & Cell Therapy’s (ESGCT) 29th Congress at Edinburgh’s (UK) International Conference Centre from October 11-14.

If you’re attending the event and would like to find out more about how our expertise, technology and manufacturing capabilities can help bring your viral vector therapies to market more effectively, please contact us to arrange a meeting.